A University of Bern spin-off, PolaSight has developed PolaOne, a label-free imaging device that produces a tissue map in one minute during cancer surgery. The start-up received a USD 100,000 investment from Constructor Capital at the Demo Day of Constructor Start.
- Announced on
- Round
- Undisclosed round
- Amount
- USD 100,000
- Location
- canton of Vaud
- Sector
- Health & medtech, Deep tech
Investors
- Constructor Capital
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic